Liver Disease

Remdesivir for COVID is now available for those with liver disease.

Remdesivir, an antiviral medication, has been given FDA approval to treat COVID-19 in patients with all stages of liver disease, according to news released on Thursday by pharmaceutical company Gilead Sciences Inc. The change is significant because, in the past, certain persons with liver illness had few alternatives for treating severe COVID-19 cases. Remdesivir, also known by the brand name Veklury, is described in a news release by Gilead as “the first and only approved antiviral COVID-19 treatment that can be used across all stages of liver disease.” Results of a Phase 1 research using the amount currently prescribed for …